[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Plasma Protein Therapeutics Market Report 2017

October 2017 | 96 pages | ID: U211324FD2FPEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Plasma Protein Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Plasma Protein Therapeutics in these regions, from 2012 to 2022 (forecast).
United States Plasma Protein Therapeutics market competition by top manufacturers/players, with Plasma Protein Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Baxter International
  • Biotest'
  • CSL Behring
  • China Biologics
  • GRIFOLS, S.A.
  • Kedrion
  • Octapharma USA, Inc.
  • Shire Plc.
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Coagulation Factors
  • Immunoglobulins
  • Albumins
  • C1 esterase Inhibitors
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Plasma Protein Therapeutics for each application, including
  • Hemophilia
  • Primary Immunodeficiency Disorder
  • Idiopathic Thrombocytopenic Purpura
  • Secondary Immunodeficiency (CLL, multiple myeloma, congenital aids)
  • Hereditary Angioedema
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Plasma Protein Therapeutics Market Report 2017

1 PLASMA PROTEIN THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Plasma Protein Therapeutics
1.2 Classification of Plasma Protein Therapeutics by Product Category
  1.2.1 United States Plasma Protein Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Plasma Protein Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Coagulation Factors
  1.2.4 Immunoglobulins
  1.2.5 Albumins
  1.2.6 C1 esterase Inhibitors
1.3 United States Plasma Protein Therapeutics Market by Application/End Users
  1.3.1 United States Plasma Protein Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hemophilia
  1.3.3 Primary Immunodeficiency Disorder
  1.3.4 Idiopathic Thrombocytopenic Purpura
  1.3.5 Secondary Immunodeficiency (CLL, multiple myeloma, congenital aids)
  1.3.6 Hereditary Angioedema
  1.3.7 Others
1.4 United States Plasma Protein Therapeutics Market by Region
  1.4.1 United States Plasma Protein Therapeutics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Plasma Protein Therapeutics Status and Prospect (2012-2022)
  1.4.3 Southwest Plasma Protein Therapeutics Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Plasma Protein Therapeutics Status and Prospect (2012-2022)
  1.4.5 New England Plasma Protein Therapeutics Status and Prospect (2012-2022)
  1.4.6 The South Plasma Protein Therapeutics Status and Prospect (2012-2022)
  1.4.7 The Midwest Plasma Protein Therapeutics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Plasma Protein Therapeutics (2012-2022)
  1.5.1 United States Plasma Protein Therapeutics Sales and Growth Rate (2012-2022)
  1.5.2 United States Plasma Protein Therapeutics Revenue and Growth Rate (2012-2022)

2 UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Plasma Protein Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Plasma Protein Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Plasma Protein Therapeutics Average Price by Players/Suppliers (2012-2017)
2.4 United States Plasma Protein Therapeutics Market Competitive Situation and Trends
  2.4.1 United States Plasma Protein Therapeutics Market Concentration Rate
  2.4.2 United States Plasma Protein Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Plasma Protein Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PLASMA PROTEIN THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Plasma Protein Therapeutics Sales and Market Share by Region (2012-2017)
3.2 United States Plasma Protein Therapeutics Revenue and Market Share by Region (2012-2017)
3.3 United States Plasma Protein Therapeutics Price by Region (2012-2017)

4 UNITED STATES PLASMA PROTEIN THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Plasma Protein Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Plasma Protein Therapeutics Revenue and Market Share by Type (2012-2017)
4.3 United States Plasma Protein Therapeutics Price by Type (2012-2017)
4.4 United States Plasma Protein Therapeutics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PLASMA PROTEIN THERAPEUTICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Plasma Protein Therapeutics Sales and Market Share by Application (2012-2017)
5.2 United States Plasma Protein Therapeutics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PLASMA PROTEIN THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Baxter International
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Plasma Protein Therapeutics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Baxter International Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Biotest?
  6.2.2 Plasma Protein Therapeutics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Biotest? Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 CSL Behring
  6.3.2 Plasma Protein Therapeutics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL Behring Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 China Biologics
  6.4.2 Plasma Protein Therapeutics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 China Biologics Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GRIFOLS, S.A.
  6.5.2 Plasma Protein Therapeutics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GRIFOLS, S.A. Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Kedrion
  6.6.2 Plasma Protein Therapeutics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Octapharma USA, Inc.
  6.7.2 Plasma Protein Therapeutics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Octapharma USA, Inc. Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Shire Plc.
  6.8.2 Plasma Protein Therapeutics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Shire Plc. Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 PLASMA PROTEIN THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Plasma Protein Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Plasma Protein Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Plasma Protein Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Plasma Protein Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Plasma Protein Therapeutics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Plasma Protein Therapeutics Sales Volume Forecast by Type (2017-2022)
11.3 United States Plasma Protein Therapeutics Sales Volume Forecast by Application (2017-2022)
11.4 United States Plasma Protein Therapeutics Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Plasma Protein Therapeutics
Figure United States Plasma Protein Therapeutics Market Size (K Units) by Type (2012-2022)
Figure United States Plasma Protein Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Coagulation Factors Product Picture
Figure Immunoglobulins Product Picture
Figure Albumins Product Picture
Figure C1 esterase Inhibitors Product Picture
Figure United States Plasma Protein Therapeutics Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Plasma Protein Therapeutics by Application in 2016
Figure Hemophilia Examples
Figure Primary Immunodeficiency Disorder Examples
Figure Idiopathic Thrombocytopenic Purpura Examples
Figure Secondary Immunodeficiency (CLL, multiple myeloma, congenital aids) Examples
Figure Hereditary Angioedema Examples
Figure Others Examples
Figure United States Plasma Protein Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure The West Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Plasma Protein Therapeutics Sales (K Units) and Growth Rate (2012-2022)
Figure United States Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Plasma Protein Therapeutics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Plasma Protein Therapeutics Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Plasma Protein Therapeutics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Plasma Protein Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Plasma Protein Therapeutics Sales Share by Players/Suppliers
Figure United States Plasma Protein Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Plasma Protein Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Plasma Protein Therapeutics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Plasma Protein Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Plasma Protein Therapeutics Revenue Share by Players/Suppliers
Table United States Market Plasma Protein Therapeutics Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Plasma Protein Therapeutics Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Plasma Protein Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Plasma Protein Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Plasma Protein Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Plasma Protein Therapeutics Product Category
Table United States Plasma Protein Therapeutics Sales (K Units) by Region (2012-2017)
Table United States Plasma Protein Therapeutics Sales Share by Region (2012-2017)
Figure United States Plasma Protein Therapeutics Sales Share by Region (2012-2017)
Figure United States Plasma Protein Therapeutics Sales Market Share by Region in 2016
Table United States Plasma Protein Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Plasma Protein Therapeutics Revenue Share by Region (2012-2017)
Figure United States Plasma Protein Therapeutics Revenue Market Share by Region (2012-2017)
Figure United States Plasma Protein Therapeutics Revenue Market Share by Region in 2016
Table United States Plasma Protein Therapeutics Price (USD/Unit) by Region (2012-2017)
Table United States Plasma Protein Therapeutics Sales (K Units) by Type (2012-2017)
Table United States Plasma Protein Therapeutics Sales Share by Type (2012-2017)
Figure United States Plasma Protein Therapeutics Sales Share by Type (2012-2017)
Figure United States Plasma Protein Therapeutics Sales Market Share by Type in 2016
Table United States Plasma Protein Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Plasma Protein Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Plasma Protein Therapeutics by Type (2012-2017)
Figure Revenue Market Share of Plasma Protein Therapeutics by Type in 2016
Table United States Plasma Protein Therapeutics Price (USD/Unit) by Types (2012-2017)
Figure United States Plasma Protein Therapeutics Sales Growth Rate by Type (2012-2017)
Table United States Plasma Protein Therapeutics Sales (K Units) by Application (2012-2017)
Table United States Plasma Protein Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Plasma Protein Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Plasma Protein Therapeutics Sales Market Share by Application in 2016
Table United States Plasma Protein Therapeutics Sales Growth Rate by Application (2012-2017)
Figure United States Plasma Protein Therapeutics Sales Growth Rate by Application (2012-2017)
Table Baxter International Basic Information List
Table Baxter International Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Baxter International Plasma Protein Therapeutics Sales Growth Rate (2012-2017)
Figure Baxter International Plasma Protein Therapeutics Sales Market Share in United States (2012-2017)
Figure Baxter International Plasma Protein Therapeutics Revenue Market Share in United States (2012-2017)
Table Biotest? Basic Information List
Table Biotest? Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biotest? Plasma Protein Therapeutics Sales Growth Rate (2012-2017)
Figure Biotest? Plasma Protein Therapeutics Sales Market Share in United States (2012-2017)
Figure Biotest? Plasma Protein Therapeutics Revenue Market Share in United States (2012-2017)
Table CSL Behring Basic Information List
Table CSL Behring Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CSL Behring Plasma Protein Therapeutics Sales Growth Rate (2012-2017)
Figure CSL Behring Plasma Protein Therapeutics Sales Market Share in United States (2012-2017)
Figure CSL Behring Plasma Protein Therapeutics Revenue Market Share in United States (2012-2017)
Table China Biologics Basic Information List
Table China Biologics Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure China Biologics Plasma Protein Therapeutics Sales Growth Rate (2012-2017)
Figure China Biologics Plasma Protein Therapeutics Sales Market Share in United States (2012-2017)
Figure China Biologics Plasma Protein Therapeutics Revenue Market Share in United States (2012-2017)
Table GRIFOLS, S.A. Basic Information List
Table GRIFOLS, S.A. Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GRIFOLS, S.A. Plasma Protein Therapeutics Sales Growth Rate (2012-2017)
Figure GRIFOLS, S.A. Plasma Protein Therapeutics Sales Market Share in United States (2012-2017)
Figure GRIFOLS, S.A. Plasma Protein Therapeutics Revenue Market Share in United States (2012-2017)
Table Kedrion Basic Information List
Table Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kedrion Plasma Protein Therapeutics Sales Growth Rate (2012-2017)
Figure Kedrion Plasma Protein Therapeutics Sales Market Share in United States (2012-2017)
Figure Kedrion Plasma Protein Therapeutics Revenue Market Share in United States (2012-2017)
Table Octapharma USA, Inc. Basic Information List
Table Octapharma USA, Inc. Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Octapharma USA, Inc. Plasma Protein Therapeutics Sales Growth Rate (2012-2017)
Figure Octapharma USA, Inc. Plasma Protein Therapeutics Sales Market Share in United States (2012-2017)
Figure Octapharma USA, Inc. Plasma Protein Therapeutics Revenue Market Share in United States (2012-2017)
Table Shire Plc. Basic Information List
Table Shire Plc. Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shire Plc. Plasma Protein Therapeutics Sales Growth Rate (2012-2017)
Figure Shire Plc. Plasma Protein Therapeutics Sales Market Share in United States (2012-2017)
Figure Shire Plc. Plasma Protein Therapeutics Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Plasma Protein Therapeutics
Figure Manufacturing Process Analysis of Plasma Protein Therapeutics
Figure Plasma Protein Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Plasma Protein Therapeutics Major Players/Suppliers in 2016
Table Major Buyers of Plasma Protein Therapeutics
Table Distributors/Traders List
Figure United States Plasma Protein Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Plasma Protein Therapeutics Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Plasma Protein Therapeutics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Plasma Protein Therapeutics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Plasma Protein Therapeutics Sales Volume (K Units) Forecast by Type in 2022
Table United States Plasma Protein Therapeutics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Plasma Protein Therapeutics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Plasma Protein Therapeutics Sales Volume (K Units) Forecast by Application in 2022
Table United States Plasma Protein Therapeutics Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Plasma Protein Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Plasma Protein Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Plasma Protein Therapeutics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories